Treatment of latent M. tuberculosis infection and use of antiretroviral therapy to prevent tuberculosis

Even with treatment of HIV with antiretroviral therapy (ART), the risk of tuberculosis (TB) reactivation remains higher in HIV-infected than HIV-uninfected persons. In this issue of the JCI, Ganatra et al. explored TB reactivation in the context of ART using TB and simian immunodeficiency virus-coin...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	The Journal of clinical investigation Ročník 130; číslo 10; s. 5102 - 5104
Hlavní autoři:	Sterling, Timothy R., Lin, Philana Ling
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States American Society for Clinical Investigation 01.10.2020
Témata:	Animals Antiretroviral agents CD4-Positive T-Lymphocytes Comorbidity Drug therapy Health aspects Highly active antiretroviral therapy HIV Infections - complications HIV Infections - drug therapy Macaca mulatta Monkeys Rifamycins Rifapentine Simian Acquired Immunodeficiency Syndrome - drug therapy Simian Immunodeficiency Virus T cells Tuberculosis Tuberculosis - drug therapy Tuberculosis - prevention & control
ISSN:	0021-9738, 1558-8238, 1558-8238
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!